Evaluation of Moosir liposomal extract on cold sore

Physicochemical characterization and clinical evaluation of final formulation of Shallomin liposomal gel on cold sore

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200819048457N1

Enrollment

Registered

2020-10-06

Start date

2015-09-23

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold sore. Herpesviral [herpes simplex] infections

Interventions

Intervention 1: Intervention group 1: Treatment using acyclovir ointment (5%), every 6h for 72h. Intervention group 2: Treatment using shallomin liposomal gel (1%), every 6 h for 72h. Intervention 2:

Eligibility

Sex/Gender

All

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the incidence of cold sore during the last 24 hours without treatment

Exclusion criteria

Exclusion criteria: Exclusion criteria: self-medication after cold sore incidence

Design outcomes

Primary

Measure	Time frame
Wound healing. Timepoint: 6, 12, 24 and 72 hours after treatment with shallomin liposomal gel. Method of measurement: Ocular.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansour Amin

Ahvaz University of Medical Sciences

mnsamin@yahoo.com+98 61 3333 5368

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026